Reuters logo
BRIEF-Galectin Therapeutics To Present Results From Phase 2B Nash-Cx Trial On December 5, 2017
December 4, 2017 / 9:15 PM / 11 days ago

BRIEF-Galectin Therapeutics To Present Results From Phase 2B Nash-Cx Trial On December 5, 2017

Dec 4 (Reuters) - Galectin Therapeutics Inc:

* GALECTIN THERAPEUTICS TO PRESENT RESULTS FROM PHASE 2B NASH-CX TRIAL ON DECEMBER 5, 2017 Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below